Article
A Simulation-Based Discrete Choice Experiment Framework for Alzheimer’s Disease-Modifying Therapy Implementation: Methodology and Interactive Decision Support Tool
2026-04-14
Abstract excerpt
<title>Abstract</title> <p> <bold>Background:</bold> Health technology assessment bodies evaluating Alzheimer’s disease-modifying therapies (DMTs) require preference-based evidence to support patient-centred decision-making. However, primary DCE data collection across multiple stakeholder groups and countries is resource-intensive and time-consuming. No published preference evidence currently exists for DMT imp...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 52d622c3-3b33-5dfd-873f-2d45b563af5b
- DOI
- 10.21203/rs.3.rs-9404461/v1
